PODD - Insulet announces proposed financing transactions
2025-03-18 07:47:20 ET
More on Insulet
- Insulet Leans Bullish (Technical Analysis)
- Insulet: Aiding Patients And Investors
- Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript
- Insulet targets 16%-20% U.S. Omnipod growth for 2025 with expanded type 2 diabetes market reach
- Insulet Non-GAAP EPS of $1.15 beats by $0.13, revenue of $597.5M beats by $15.48M